PetCaseFinder

Peer-reviewed veterinary case report

Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines againstReveals Remarkable Role of Fluorine.

Journal:
Journal of medicinal chemistry
Year:
2023
Authors:
Schubert, Tanner J et al.
Affiliation:
Department of Chemistry · United States

Abstract

Our previous work identified compound(SLU-2633) as a potent lead compound toward the identification of a novel treatment for cryptosporidiosis, caused by the parasite(EC= 0.17 &#x3bc;M). While this compound is potent and orally efficacious, the mechanism of action and biological target(s) of this series are currently unknown. In this study, we synthesized 70 compounds to develop phenotypic structure-activity relationships around the aryl "tail" group. In this process, we found that 2-substituted compounds are inactive, confirmed that electron withdrawing groups are preferred over electron donating groups, and that fluorine plays a remarkable role in the potency of these compounds. The most potent compound resulting from this work is SLU-10482 (, EC= 0.07 &#x3bc;&#x39c;), which was found to be orally efficacious with an ED< 5 mg/kg BID in a-infection mouse model, superior to SLU-2633.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication: https://pubmed.ncbi.nlm.nih.gov/37267631/